What do solid tumours, certain congenital types of deafness and rheumatoid arthritis have in common? A deregulation in the function of the protein KIAA1199! In a study published in Nature communications, a team of researchers - lead by Pr Alain Chariot - from the University of Liège reveal the link between this protein and a receptor known as EGFR, a key protagonist in tumour development and progression. A link that could be of importance for these human diseases...
Read the article
(1) Kateryna Shostak, Xin Zhang, Pascale Hubert, Serkan Ismail Göktuna, Zheshen Jiang, Iva Klevernic, Julien Hildebrand, Patrick Roncarati, Benoit Hennuy, Aurélie Ladang, Joan Somja, André Gothot, Pierre Close, Philippe Delvenne & Alain Chariot. NF-κB-induced KIAA1199 promotes survival through EGFR signalling. Nature communications| 5:5232 | DOI: 10.1038/ncomms6232 | |
|
|